BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8990172)

  • 1. PU.1 can participate in an active enhancer complex without its transcriptional activation domain.
    Pongubala JM; Atchison ML
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):127-32. PubMed ID: 8990172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-step mechanism for recruitment of Pip by PU.1.
    Perkel JM; Atchison ML
    J Immunol; 1998 Jan; 160(1):241-52. PubMed ID: 9551977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains.
    Nagulapalli S; Atchison ML
    Mol Cell Biol; 1998 Aug; 18(8):4639-50. PubMed ID: 9671474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain.
    Rieske P; Pongubala JM
    J Biol Chem; 2001 Mar; 276(11):8460-8. PubMed ID: 11133986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity.
    Bai Y; Srinivasan L; Perkins L; Atchison ML
    J Immunol; 2005 Oct; 175(8):5160-9. PubMed ID: 16210620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
    Brass AL; Kehrli E; Eisenbeis CF; Storb U; Singh H
    Genes Dev; 1996 Sep; 10(18):2335-47. PubMed ID: 8824592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative hydroxyl radical footprinting reveals cooperative interactions between DNA-binding subdomains of PU.1 and IRF4.
    Gross P; Yee AA; Arrowsmith CH; Macgregor RB
    Biochemistry; 1998 Jul; 37(27):9802-11. PubMed ID: 9657694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
    Su GH; Ip HS; Cobb BS; Lu MM; Chen HM; Simon MC
    J Exp Med; 1996 Jul; 184(1):203-14. PubMed ID: 8691135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene.
    Krysinska H; Hoogenkamp M; Ingram R; Wilson N; Tagoh H; Laslo P; Singh H; Bonifer C
    Mol Cell Biol; 2007 Feb; 27(3):878-87. PubMed ID: 17116688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.
    Pongubala JM; Atchison ML
    J Biol Chem; 1995 Apr; 270(17):10304-13. PubMed ID: 7730336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
    Brass AL; Zhu AQ; Singh H
    EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1-mediated transcription is enhanced by HMG-I(Y)-dependent structural mechanisms.
    Lewis RT; Andreucci A; Nikolajczyk BS
    J Biol Chem; 2001 Mar; 276(12):9550-7. PubMed ID: 11124259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1.
    Rao S; Matsumura A; Yoon J; Simon MC
    J Biol Chem; 1999 Apr; 274(16):11115-24. PubMed ID: 10196196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts.
    Nagulapalli S; Goheer A; Pitt L; McIntosh LP; Atchison ML
    Mol Cell Biol; 2002 Oct; 22(20):7337-50. PubMed ID: 12242308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMA/ionomycin induces Ig kappa 3' enhancer activity which is in part mediated by a unique NFAT transcription complex.
    Meyer KB; Ireland J
    Eur J Immunol; 1998 May; 28(5):1467-80. PubMed ID: 9603451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S; Atchison ML; Fenton MJ
    J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An AP1 binding site upstream of the kappa immunoglobulin intron enhancer binds inducible factors and contributes to expression.
    Schanke JT; Marcuzzi A; Podzorski RP; Van Ness B
    Nucleic Acids Res; 1994 Dec; 22(24):5425-32. PubMed ID: 7816634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3).
    Nagulapalli S; Pongubala JM; Atchison ML
    J Immunol; 1995 Nov; 155(9):4330-8. PubMed ID: 7594592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.